Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 46% ± 21% | |
lung | 7 studies | 34% ± 13% | |
heart | 5 studies | 38% ± 13% | |
eye | 5 studies | 50% ± 19% | |
peripheral blood | 3 studies | 21% ± 1% | |
liver | 3 studies | 43% ± 17% | |
intestine | 3 studies | 19% ± 1% | |
adipose | 3 studies | 46% ± 14% | |
kidney | 3 studies | 33% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 6411.05 | 21 / 21 | 100% | 40.56 | 504 / 504 |
breast | 100% | 5939.09 | 459 / 459 | 100% | 54.47 | 1118 / 1118 |
esophagus | 100% | 5897.60 | 1445 / 1445 | 100% | 58.81 | 183 / 183 |
intestine | 100% | 6440.42 | 966 / 966 | 100% | 37.11 | 527 / 527 |
liver | 100% | 2919.67 | 226 / 226 | 100% | 22.82 | 406 / 406 |
lung | 100% | 6073.72 | 578 / 578 | 100% | 41.87 | 1155 / 1155 |
ovary | 100% | 6862.43 | 180 / 180 | 100% | 32.27 | 430 / 430 |
pancreas | 100% | 2775.21 | 328 / 328 | 100% | 34.09 | 178 / 178 |
prostate | 100% | 6349.48 | 245 / 245 | 100% | 44.79 | 502 / 502 |
stomach | 100% | 4668.60 | 359 / 359 | 100% | 39.81 | 286 / 286 |
thymus | 100% | 8683.30 | 653 / 653 | 100% | 43.29 | 605 / 605 |
uterus | 100% | 6450.10 | 170 / 170 | 100% | 38.32 | 459 / 459 |
kidney | 100% | 3953.46 | 89 / 89 | 100% | 32.64 | 899 / 901 |
brain | 100% | 3273.86 | 2633 / 2642 | 100% | 33.49 | 705 / 705 |
adrenal gland | 100% | 5784.59 | 258 / 258 | 98% | 23.91 | 226 / 230 |
skin | 100% | 5271.62 | 1809 / 1809 | 96% | 34.77 | 455 / 472 |
adipose | 100% | 5417.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5386.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.30 | 29 / 29 |
muscle | 100% | 5697.00 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6321.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.28 | 1 / 1 |
heart | 99% | 3784.27 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 3749.23 | 874 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 16.33 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043666 | Biological process | regulation of phosphoprotein phosphatase activity |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019888 | Molecular function | protein phosphatase regulator activity |
GO_0005515 | Molecular function | protein binding |
GO_0019903 | Molecular function | protein phosphatase binding |
Gene name | PPP6R3 |
Protein name | Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) Protein phosphatase 6 regulatory subunit 3 |
Synonyms | SAPL SAPS3 C11orf23 KIAA1558 PP6R3 |
Description | FUNCTION: Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. May have an important role in maintaining immune self-tolerance. . |
Accessions | E9PQP7 ENST00000529907.5 E9PKG4 ENST00000525421.5 H0YEV0 ENST00000524845.5 [Q5H9R7-6] H0YEN2 E9PNN8 ENST00000531244.1 ENST00000534190.5 ENST00000526593.1 E9PK08 ENST00000393800.7 [Q5H9R7-1] ENST00000527403.6 Q5H9R7 H0YDW1 ENST00000529710.5 [Q5H9R7-3] ENST00000530734.1 H0YDK9 ENST00000528635.5 H7BXH2 E9PKF6 ENST00000534534.5 ENST00000524904.5 [Q5H9R7-2] ENST00000265636.9 [Q5H9R7-4] ENST00000533127.5 ENST00000393801.7 [Q5H9R7-5] ENST00000265637.8 ENST00000529344.5 A0A1D5RMU2 E9PJD8 |